Aditi Dutt

Array ( [id] => 5821258 [patent_doc_number] => 20060025571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Morphogen-induced dendritic growth' [patent_app_type] => utility [patent_app_number] => 11/226555 [patent_app_country] => US [patent_app_date] => 2005-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 32730 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025571.pdf [firstpage_image] =>[orig_patent_app_number] => 11226555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655195 [patent_doc_number] => 20060140930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Promotion of central nervous system remyelination using monoclonal autoantibodies' [patent_app_type] => utility [patent_app_number] => 11/224664 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15854 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140930.pdf [firstpage_image] =>[orig_patent_app_number] => 11224664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5595710 [patent_doc_number] => 20060159626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Method for administering a cytokine to the central nervous system and the lymphatic system' [patent_app_type] => utility [patent_app_number] => 11/222669 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26566 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20060159626.pdf [firstpage_image] =>[orig_patent_app_number] => 11222669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279177 [patent_doc_number] => 20090131309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'ICA512 COUPLES INSULIN SECRETION AND GENE EXPRESSION IN BETA-CELLS' [patent_app_type] => utility [patent_app_number] => 11/574568 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 32119 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131309.pdf [firstpage_image] =>[orig_patent_app_number] => 11574568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5770680 [patent_doc_number] => 20050266504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Methods for diagnosing and treating Alzheimers disease and Parkinson\'s disease' [patent_app_type] => utility [patent_app_number] => 11/147022 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18988 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266504.pdf [firstpage_image] =>[orig_patent_app_number] => 11147022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5677748 [patent_doc_number] => 20060183104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Cellular models of neuron-associated disorders and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/196376 [patent_app_country] => US [patent_app_date] => 2005-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 16165 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183104.pdf [firstpage_image] =>[orig_patent_app_number] => 11196376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205597 [patent_doc_number] => 20070027079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'GHRP 2 strips' [patent_app_type] => utility [patent_app_number] => 11/189962 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2486 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027079.pdf [firstpage_image] =>[orig_patent_app_number] => 11189962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434949 [patent_doc_number] => 20090169535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'TREATMENT OF EPILEPSY BY EXPRESSING ST3GAL-III' [patent_app_type] => utility [patent_app_number] => 11/658830 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13281 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169535.pdf [firstpage_image] =>[orig_patent_app_number] => 11658830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 190761 [patent_doc_number] => 07642072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-05 [patent_title] => 'Optimized interferon-beta gene' [patent_app_type] => utility [patent_app_number] => 11/571479 [patent_app_country] => US [patent_app_date] => 2005-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 2605 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/642/07642072.pdf [firstpage_image] =>[orig_patent_app_number] => 11571479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5619981 [patent_doc_number] => 20060189515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Molecules for transporting a compound across the blood-brain barrier' [patent_app_type] => utility [patent_app_number] => 11/185947 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17171 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189515.pdf [firstpage_image] =>[orig_patent_app_number] => 11185947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8532904 [patent_doc_number] => 08309057 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Methods for elevating neurotrophic agents' [patent_app_type] => utility [patent_app_number] => 11/150861 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12402 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11150861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4791855 [patent_doc_number] => 20080292828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Composition Comprising Various Proteorhodopsins and/or Bacteriorhodopsins and Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/569862 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9209 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292828.pdf [firstpage_image] =>[orig_patent_app_number] => 11569862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829404 [patent_doc_number] => 20060063923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => '4-1BB peptides and methods for use' [patent_app_type] => utility [patent_app_number] => 11/147916 [patent_app_country] => US [patent_app_date] => 2005-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 35525 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063923.pdf [firstpage_image] =>[orig_patent_app_number] => 11147916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977945 [patent_doc_number] => 20050287663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'DNA encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor, cells transformed therewith, and a recombinant cell line expressing a functional human alpha7 subunit of neuronal nicotinic acetylcholine receptor' [patent_app_type] => utility [patent_app_number] => 11/122144 [patent_app_country] => US [patent_app_date] => 2005-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 25193 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287663.pdf [firstpage_image] =>[orig_patent_app_number] => 11122144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7110573 [patent_doc_number] => 20050208028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Nutrient Medium for maintaining neural cells in injured nervous system' [patent_app_type] => utility [patent_app_number] => 11/115479 [patent_app_country] => US [patent_app_date] => 2005-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11704 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208028.pdf [firstpage_image] =>[orig_patent_app_number] => 11115479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7050290 [patent_doc_number] => 20050186177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Liquid interferon-beta formulations' [patent_app_type] => utility [patent_app_number] => 11/102723 [patent_app_country] => US [patent_app_date] => 2005-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7271 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186177.pdf [firstpage_image] =>[orig_patent_app_number] => 11102723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5608447 [patent_doc_number] => 20060269963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Composition for the diagnosis of retinal vascular disease comprising aldolase and method for diagnosis using it' [patent_app_type] => utility [patent_app_number] => 10/555025 [patent_app_country] => US [patent_app_date] => 2005-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5033 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269963.pdf [firstpage_image] =>[orig_patent_app_number] => 10555025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259054 [patent_doc_number] => 20070212686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Use Of T-Cadherin As A Target' [patent_app_type] => utility [patent_app_number] => 10/553430 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16475 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212686.pdf [firstpage_image] =>[orig_patent_app_number] => 10553430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7116644 [patent_doc_number] => 20050069945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Human chemotactic cytokine I polypeptides' [patent_app_type] => utility [patent_app_number] => 10/994821 [patent_app_country] => US [patent_app_date] => 2004-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13647 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069945.pdf [firstpage_image] =>[orig_patent_app_number] => 10994821 [rel_patent_id] =>[rel_patent_doc_number] =>)